Cancer and kidney diseases (KD) intersect in many ways resulting in worse outcomes. Both conditions are correlated with cognitive impairment, which can be exacerbated in cancer patients by known effects of many antineoplastic drugs on cognition, leading to a phenomenon known as chemotherapy-related cognitive impairment (CRCI). This manifests as poor attention span, disturbed short-term memory, and general mental sluggishness. This literature review explores CRCI and investigates the potential impact of KD on this phenomenon. Additionally, we highlight the shared pathogenetic mechanisms (including neurotoxicity, neuroinflammation, oxidative stress, vascular disease, electrolyte, and acid-base imbalances), clinical presentation and imaging findings between cognitive impairment in KD and CRCI. The disruption of the blood–brain barrier might be a key mechanism for increased brain permeability to anticancer drugs in nephropathic patients with cancer. Based on existing knowledge, we found a potential for heightened neurotoxicity of antineoplastic drugs and a synergistic potentiation of cognitive impairment in cancer patients with KD. However, further translational research is urgently required to validate this hypothesis.

Chemotherapy-related cognitive impairment and kidney dysfunction / Simeoni, M.; Mulholland, M. M.; Workeneh, B. T.; Capasso, A.; Hafez, G.; Liabeuf, S.; Malyszko, J.; Mani, L. -Y.; Trevisani, F.; De, A.; Wagner, C. A.; Massy, Z. A.; Unwin, R.; Capasso, G.; Andrade, A.; Arici, M.; Bachmann, M.; Bailey, M.; Barbieri, M.; Bobot, M.; Bruchfeld, A.; Arune-Bumblyte, I.; Rastenyte, D.; Calcutta, A.; Capolongo, G.; Carriazo, S.; Ceccarelli, M.; Constantin Covic, A.; Delgado, P.; Endlich, N.; Endres, M.; Esposito, F.; Farisco, M.; Faucher, Q.; Carina Ferreira, A.; Figurek, A.; Fouque, D.; Franssen, C.; Fridolin, I.; Frische, S.; Garneata, L.; Gesualdo, L.; Giannakou, K.; Godefroy, O.; Golenia, A.; Goumenos, D.; Gutierrez Jimenez, E.; Hoorn, E.; Henrique Imenez Silva, P.; Izhar, R.; Kelly, D.; Kesler, S.; Klimkowicz-Mrowiec, A.; Knauss, S.; Kurganaite, J.; Levassort, H.; Martino, G.; Massy, Z.; Mayer, C.; Mucci, A.; Mutevelic-Turkovic, A.; Nielsen, R.; Nitsch, D.; Ortiz, A.; Panagiotopoulos, V.; Karasavvidou, D.; Paolisso, G.; Pejuskovic, B.; Pepin, M.; Perna, A.; Perrottelli, A.; Pesic, V.; Pezzella, P.; Rroji, M.; Rychlik, I.; Sakkas, G.; Jose Soler Romeo, M.; Spasovski, G.; Starcevic, A.; Tedeschi, G.; Vazelov, E.; Wagner, C. A.; Wagner, F.; Wanner, C.; Wiecek, A.; Xu, H.; Zacchia, M.; Zacharia, L.; Zecchino, I.; Zoccali, C.; Mattace-Raso, F.; Endlich, K. -H.; Perico, N.; Remuzzi, G.; Trepiccione, F.; Okusa, M.; Di Marzo, V.; Blankestijn, P.; Eckardt, K. -U.; Konig, M.; Gansevoort, R.; Askari, H.; Hansen, B.; Snaedal, S.; Cuiban, E.; Caporusso, E.; Lo Re, V.; Roiser, J.; Rosenberg, K.; Bisecco, A.; Denby, L.; Prakash Kulkarni, O.; Sharma, K.; Debnath, S.; Jaafar, A.; Mulholland, M.; Workeneh, B.; Iervolino, A.; Fraser, S.; Frey-Wagner, I.; Pastore, A.; De Donato, A.; Maciulaitis, R.; Farinha, A.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 40:(2025), pp. 54-63. [10.1093/ndt/gfae249]

Chemotherapy-related cognitive impairment and kidney dysfunction

Capasso A.;Trevisani F.;Martino G.;
2025-01-01

Abstract

Cancer and kidney diseases (KD) intersect in many ways resulting in worse outcomes. Both conditions are correlated with cognitive impairment, which can be exacerbated in cancer patients by known effects of many antineoplastic drugs on cognition, leading to a phenomenon known as chemotherapy-related cognitive impairment (CRCI). This manifests as poor attention span, disturbed short-term memory, and general mental sluggishness. This literature review explores CRCI and investigates the potential impact of KD on this phenomenon. Additionally, we highlight the shared pathogenetic mechanisms (including neurotoxicity, neuroinflammation, oxidative stress, vascular disease, electrolyte, and acid-base imbalances), clinical presentation and imaging findings between cognitive impairment in KD and CRCI. The disruption of the blood–brain barrier might be a key mechanism for increased brain permeability to anticancer drugs in nephropathic patients with cancer. Based on existing knowledge, we found a potential for heightened neurotoxicity of antineoplastic drugs and a synergistic potentiation of cognitive impairment in cancer patients with KD. However, further translational research is urgently required to validate this hypothesis.
2025
Inglese
Oxford University Press
40
54
63
10
Pubblicato
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
anticancer drugs
blood–brain barrier
chemotherapy-related cognitive impairment
chronic kidney disease
neurotoxicity
Chemotherapy-related cognitive impairment and kidney dysfunction / Simeoni, M.; Mulholland, M. M.; Workeneh, B. T.; Capasso, A.; Hafez, G.; Liabeuf, S.; Malyszko, J.; Mani, L. -Y.; Trevisani, F.; De, A.; Wagner, C. A.; Massy, Z. A.; Unwin, R.; Capasso, G.; Andrade, A.; Arici, M.; Bachmann, M.; Bailey, M.; Barbieri, M.; Bobot, M.; Bruchfeld, A.; Arune-Bumblyte, I.; Rastenyte, D.; Calcutta, A.; Capolongo, G.; Carriazo, S.; Ceccarelli, M.; Constantin Covic, A.; Delgado, P.; Endlich, N.; Endres, M.; Esposito, F.; Farisco, M.; Faucher, Q.; Carina Ferreira, A.; Figurek, A.; Fouque, D.; Franssen, C.; Fridolin, I.; Frische, S.; Garneata, L.; Gesualdo, L.; Giannakou, K.; Godefroy, O.; Golenia, A.; Goumenos, D.; Gutierrez Jimenez, E.; Hoorn, E.; Henrique Imenez Silva, P.; Izhar, R.; Kelly, D.; Kesler, S.; Klimkowicz-Mrowiec, A.; Knauss, S.; Kurganaite, J.; Levassort, H.; Martino, G.; Massy, Z.; Mayer, C.; Mucci, A.; Mutevelic-Turkovic, A.; Nielsen, R.; Nitsch, D.; Ortiz, A.; Panagiotopoulos, V.; Karasavvidou, D.; Paolisso, G.; Pejuskovic, B.; Pepin, M.; Perna, A.; Perrottelli, A.; Pesic, V.; Pezzella, P.; Rroji, M.; Rychlik, I.; Sakkas, G.; Jose Soler Romeo, M.; Spasovski, G.; Starcevic, A.; Tedeschi, G.; Vazelov, E.; Wagner, C. A.; Wagner, F.; Wanner, C.; Wiecek, A.; Xu, H.; Zacchia, M.; Zacharia, L.; Zecchino, I.; Zoccali, C.; Mattace-Raso, F.; Endlich, K. -H.; Perico, N.; Remuzzi, G.; Trepiccione, F.; Okusa, M.; Di Marzo, V.; Blankestijn, P.; Eckardt, K. -U.; Konig, M.; Gansevoort, R.; Askari, H.; Hansen, B.; Snaedal, S.; Cuiban, E.; Caporusso, E.; Lo Re, V.; Roiser, J.; Rosenberg, K.; Bisecco, A.; Denby, L.; Prakash Kulkarni, O.; Sharma, K.; Debnath, S.; Jaafar, A.; Mulholland, M.; Workeneh, B.; Iervolino, A.; Fraser, S.; Frey-Wagner, I.; Pastore, A.; De Donato, A.; Maciulaitis, R.; Farinha, A.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 40:(2025), pp. 54-63. [10.1093/ndt/gfae249]
none
124
info:eu-repo/semantics/article
262
Simeoni, M.; Mulholland, M. M.; Workeneh, B. T.; Capasso, A.; Hafez, G.; Liabeuf, S.; Malyszko, J.; Mani, L. -Y.; Trevisani, F.; De, A.; Wagner, C. A....espandi
1 Contributo su Rivista::1.1.1 Articolo in rivista - Review
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/203084
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact